Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism: Procedural and follow-up results after implantation of the Amplatzer®-occluder device

Journal of Interventional Cardiology

Volumn 24, Issue 1, 2011, Pages 85-91

  Fischer, Dieter ^a   Haentjes, Jonas ^a   Klein, Gunnar ^a   Schieffer, Bernhard ^a   Drexler, Helmut ^a   Meyer, Gerd P ^a   Schaefer, Arnd ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; ANTICOAGULATION; ARTERIOVENOUS FISTULA; ARTICLE; BACTERIAL ENDOCARDITIS; CONSERVATIVE TREATMENT; FEMALE; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PRIORITY JOURNAL; SEIZURE; SEPTAL OCCLUDER; STROKE; THROMBOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION;

ASPIRIN; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SEPTAL OCCLUDER DEVICE; STROKE; THROMBOEMBOLISM; TICLOPIDINE;

EID: 79951594420     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00593.x     Document Type: Article

References (26)

1. Di Tullio, M, Sacco RL, Gopal A, et al,. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992; 117 (6): 461-465.
2. Lechat, P, Mas JL, Lascault G, et al,. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318 (18): 1148-1152.
3. Bogousslavsky, J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovale: The Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996; 46 (5): 1301-1305. (Pubitemid 26159291)
4. Hanna, JP, Sun JP, Furlan AJ, et al,. Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 1994; 25 (4): 782-786. (Pubitemid 24111323)
5. Hausmann, D, Mugge, A, Daniel, WG,. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 1995; 26 (4): 1030-1038.
6. Homma, S, Di Tullio MR, Sacco Rl, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke. A biplane transesophageal echocardiographic study. Stroke 1994; 25 (3): 582-586.
7. Cabanes, L, Mas L, Cohen A, et al,. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993; 24 (12): 1865-1873. (Pubitemid 23352717)
8. Stone, DA, Godard J, Corretti MC, et al,. Patent foramen ovale: Association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Am Heart J 1996; 131 (1): 158-161. (Pubitemid 26021379)
9. Bridges, ND, Hellenbrand W, Latson L, et al,. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992; 86 (6): 1902-1908.
10. Windecker, S, Wahl A, Chatterjee T, et al,. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events. Circulation 2000; 101 (8): 893-898. (Pubitemid 30117885)
11. Braun, M, Gliech V, Boscheri A, et al,. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems. Eur Heart J 2004; 25 (5): 424-430. (Pubitemid 38391525)
12. Wahl, A, Krumsdorf U, Meier B, et al,. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol 2005; 45 (3): 377-380. (Pubitemid 40186787)
13. Windecker, S, Wahl A, Nedeltchev K, et al,. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004; 44 (4): 750-758. (Pubitemid 39099567)
14. Schwerzmann, M, Windecker S, Wahl A, et al,. Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart. 2004; 90: 186-190. (Pubitemid 38147155)
15. Krumsdorf, U, Keppeler P, Horvath K, et al,. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol 2001; 14 (1): 49-55. (Pubitemid 32216234)
16. Fischer, D, Fuchs M, Schaefer A, et al,. Transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Procedural and follow-up results after implantation of the Starflex occluder device with conjunctive intensified anticoagulation regimen. J Interv Cardiol 2008; 21 (2): 183-189. (Pubitemid 351490137)
17. von Bardeleben, RS, Richter C, Otto J, et al,. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm. Int J Cardiol 2009; 134 (1): 33-41.
18. Taaffe, M, Fischer E, Baranowski A, et al,. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol 2008; 101 (9): 1353-1358.
19. Krumsdorf, U, Ostermayer S, Billinger K, et al,. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004; 43 (2): 302-309. (Pubitemid 38201160)
20. Webster, MW, Chancellor AM, Smith HJ, et al,. Patent foramen ovale in young stroke patients. Lancet 1988; 2 (8601): 11-12.
21. Mugge, A, Daniel WG, Angermann C, et al,. Atrial septal aneurysm in adult patients. A multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995; 91 (11): 2785-2792.
22. Mas, JL, Arquizan C, Lamy C, et al,. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345 (24): 1740-1746.
23. Homma, S, Di Tullio MR, Sacco RL, et al,. Surgical closure of patent foramen ovale in cryptogenic stroke patients. Stroke, 1997; 28 (12): 2376-2381. (Pubitemid 28007635)
24. Dearani, JA, Ugurlu BS, Danielson GK, et al,. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999; 100 (19 Suppl): II171-II175. (Pubitemid 29523530)
25. Chatterjee, T, Petzsch M, Ince H, et al,. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism. J Interv Cardiol 2005; 18 (3): 173-179. (Pubitemid 40942728)
26. Schneider, B, Bauer, R,. Is surgical closure of patent foramen ovale the gold standard for treating interatrial shunts? An echocardiographic follow-up study. J Am Soc Echocardiogr 2005; 18 (12): 1385-1391. (Pubitemid 41821186)